OUR VISION By addressing the unmet medical needs of our
patients with paradigm-shifting therapeutics
WE ASPIRE TO CONQUER CANCER

Pipeline

*Also known as VIP152.
ADC, antibody-drug conjugate; CDK, cyclin-dependent kinase; DLBCL, diffuse large B-cell Lymphoma; GCB, germinal center B-cell; IV, intravenous; KSPi, kinesin spindle protein inhibitor; MDS, myelodysplastic syndrome; optCPT, optimized camptothecin; P-TEFb, positive transcription elongation factor B; SMDC, small molecule drug conjugate.

VINCERX PHARMA
NEWS

Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023

Menu